1.  Identification of Risk Factors: Recognizing and comprehending the risk factors linked to pregnancy induced hypertension can help detect at risk women in their early stages. Several factors have been linked to pre-eclampsia or hypertension in prior pregnancies, obesity, numerous gestations, and advanced maternal age. Improved risk stratification and focused interventions are made possible by a thorough investigation that can confirm these risk variables and uncover new ones.

2.  Management and Drug Utilization: The treatment of pregnancy induced hypertension frequently includes the use of antihypertensive medicines and other therapeutic approaches. Analyzing drug use trends can show existing procedures, compliance with guidelines, and places for improvement. This can lead to more effective treatment methods that improve mother and fetal health.

3.  Comparative Analysis of PIH Types: This study will look at gestational hypertension, pre-eclampsia (with and without proteinuria), and eclampsia (with convulsions) to see how they differ in risk factors, progression, and management needs. This distinction is critical for customizing individual treatment approaches to each kind of pregnancy induced hypertension.

4.  Outcome Improvement: The ultimate purpose of this study is to enhance clinical outcomes for women with pregnancy induced hypertension. Healthcare practitioners can design more effective prevention and management strategies by understanding risk factors and drug consumption patterns, lowering the occurrence of serious problems and improving the general health of pregnant women and their newborns.